Enzinger PC, Mayer RJ: Esophageal cancer. N Engl J Med. 2003, 349 (23): 2241-2252. 10.1056/NEJMra035010.
Article
CAS
PubMed
Google Scholar
Nebert DW, Roe AL, Vandale SE, Bingham E, Oakley GG: NAD(P)H:quinone oxidoreductase (NQO1) polymorphism, exposure to benzene, and predisposition to disease: a HuGE review. Genet Med. 2002, 4 (2): 62-70. 10.1097/00125817-200203000-00003.
Article
CAS
PubMed
Google Scholar
Larson RA, Wang Y, Banerjee M, Wiemels J, Hartford C, Le Beau MM, Smith MT: Prevalence of the inactivating 609C→T polymorphism in the NAD(P)H:quinone oxidoreductase (NQO1) gene in patients with primary and therapy-related myeloid leukemia. Blood. 1999, 94 (2): 803-807.
CAS
PubMed
Google Scholar
Siegel D, Anwar A, Winski SL, Kepa JK, Zolman KL, Ross D: Rapid polyubiquitination and proteasomal degradation of a mutant form of NAD(P)H: quinone oxidoreductase 1. Mol Pharmacol. 2001, 59 (2): 263-268.
CAS
PubMed
Google Scholar
Kuehl BL, Paterson JW, Peacock JW, Paterson MC, Rauth AM: Presence of a heterozygous substitution and its relationship to DT-diaphorase activity. Br J Cancer. 1995, 72 (3): 555-561. 10.1038/bjc.1995.373.
Article
CAS
PubMed
PubMed Central
Google Scholar
Moran JL, Siegel D, Ross D: A potential mechanism underlying the increased susceptibility of individuals with a polymorphism in NAD(P)H:quinone oxidoreductase 1 (NQO1) to benzene toxicity. Proc Natl Acad Sci USA. 1999, 96 (14): 8150-8155. 10.1073/pnas.96.14.8150.
Article
CAS
PubMed
PubMed Central
Google Scholar
Smith MT: Benzene, NQO1, and genetic susceptibility to cancer. Proc Natl Acad Sci USA. 1999, 96 (14): 7624-7626. 10.1073/pnas.96.14.7624.
Article
CAS
PubMed
PubMed Central
Google Scholar
Schulz WA, Krummeck A, Rosinger I, Eickelmann P, Neuhaus C, Ebert T, Schmitz-Drager BJ, Sies H: Increased frequency of a null-allele for NAD(P)H: quinone oxidoreductase in patients with urological malignancies. Pharmacogenetics. 1997, 7 (3): 235-239. 10.1097/00008571-199706000-00008.
Article
CAS
PubMed
Google Scholar
Chen H, Lum A, Seifried A, Wilkens LR, Le Marchand L: Association of the NAD(P)H:quinone oxidoreductase 609C→T polymorphism with a decreased lung cancer risk. Cancer Res. 1999, 59 (13): 3045-3048.
CAS
PubMed
Google Scholar
Xu LL, Wain JC, Miller DP, Thurston SW, Su L, Lynch TJ, Christiani DC: The NAD(P)H:quinone oxidoreductase 1 gene polymorphism and lung cancer: differential susceptibility based on smoking behavior. Cancer Epidemiol Biomarkers Prev. 2001, 10 (4): 303-309.
CAS
PubMed
Google Scholar
Radjendirane V, Joseph P, Lee YH, Kimura S, Klein-Szanto AJ, Gonzalez FJ, Jaiswal AK: Disruption of the DT diaphorase (NQO1) gene in mice leads to increased menadione toxicity. J Biol Chem. 1998, 273 (13): 7382-7389. 10.1074/jbc.273.13.7382.
Article
CAS
PubMed
Google Scholar
Klaidman LK, Leung AC, Adams JD: High-performance liquid chromatography analysis of oxidized and reduced pyridine dinucleotides in specific brain regions. Anal Biochem. 1995, 228 (2): 312-317. 10.1006/abio.1995.1356.
Article
CAS
PubMed
Google Scholar
Long DJ, Gaikwad A, Multani A, Pathak S, Montgomery CA, Gonzalez FJ, Jaiswal AK: Disruption of the NAD(P)H:quinone oxidoreductase 1 (NQO1) gene in mice causes myelogenous hyperplasia. Cancer Res. 2002, 62 (11): 3030-3036.
CAS
PubMed
Google Scholar
Sameer AS, Shah ZA, Syeed N, Rasool R, Afroze D, Siddiqi MA: NAD(P)H:quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and colorectal cancer predisposition in the ethnic Kashmiri population. Asian Pac j cancer prev: APJCP. 2010, 11 (1): 209-213.
PubMed
Google Scholar
Cho CG, Lee SK, Nam SY, Lee MS, Lee SW, Choi EK, Park HJ, Kim SY: Association of the GSTP1 and NQO1 polymorphisms and head and neck squamous cell carcinoma risk. J Korean Med Sci. 2006, 21 (6): 1075-1079. 10.3346/jkms.2006.21.6.1075.
Article
CAS
PubMed
PubMed Central
Google Scholar
Ioannidis JP, Ntzani EE, Trikalinos TA: ‘Racial’ differences in genetic effects for complex diseases. Nat Genet. 2004, 36 (12): 1312-1318. 10.1038/ng1474.
Article
CAS
PubMed
Google Scholar
Thakkinstian A, McElduff P, D’Este C, Duffy D, Attia J: A method for meta-analysis of molecular association studies. Stat Med. 2005, 24 (9): 1291-1306. 10.1002/sim.2010.
Article
PubMed
Google Scholar
Thakkinstian A, McEvoy M, Minelli C, Gibson P, Hancox B, Duffy D, Thompson J, Hall I, Kaufman J, Leung TF: Systematic review and meta-analysis of the association between {beta}2-adrenoceptor polymorphisms and asthma: a HuGE review. Am J Epidemiol. 2005, 162 (3): 201-211. 10.1093/aje/kwi184.
Article
PubMed
Google Scholar
Petiti DB: Meta-analysis, decision analysis, and cost-effectiveness analysis. 1994, Oxford: Oxford University Press
Google Scholar
Higgins JP, Thompson SG, Deeks JJ, Altman DG: Measuring inconsistency in meta-analyses. BMJ. 2003, 327 (7414): 557-560. 10.1136/bmj.327.7414.557.
Article
PubMed
PubMed Central
Google Scholar
Egger M, Davey Smith G, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997, 315 (7109): 629-634. 10.1136/bmj.315.7109.629.
Article
CAS
PubMed
PubMed Central
Google Scholar
Li Y, Zhang JH, Guo W, Wang R, Wen DG, Wei LZ: Polymorphism of NAD(P)H dehydrogenase (quinone) 1 (NQO1) C 609 T and risk of esophageal neoplasm. Zhonghua Liu Xing Bing Xue Za Zhi. 2004, 25 (8): 731-
CAS
PubMed
Google Scholar
Zhang JH, Li Y, Wang R, Sarbia M, Guo W, Wen DG, Wei LZ, Chen ZF, Kuang G, Zhang LW: The NAD(P)H: quinone oxidoreductase 1 C609T polymorphism and susceptibility to esophageal cancer. Zhonghua Xue Yi Chuan Xue Za Zhi. 2003, 20 (6): 544-546.
CAS
Google Scholar
di Martino E, Hardie LJ, Wild CP, Gong YY, Olliver JR, Gough MD, Bird NC: The NAD(P)H:quinone oxidoreductase I C609T polymorphism modifies the risk of Barrett esophagus and esophageal adenocarcinoma. Genet Med. 2007, 9 (6): 341-347. 10.1097/GIM.0b013e3180654ccd.
Article
CAS
PubMed
Google Scholar
Hamajima N, Matsuo K, Iwata H, Shinoda M, Yamamura Y, Kato T, Hatooka S, Mitsudomi T, Suyama M, Kagami Y: NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism and the risk of eight cancers for Japanese. Int J Clin Oncol. 2002, 7 (2): 103-108.
CAS
PubMed
Google Scholar
Marjani HA, Biramijamal F, Rakhshani N, Hossein-Nezhad A, Malekzadeh R: Investigation of NQO1 genetic polymorphism, NQO1 gene expression and PAH-DNA adducts in ESCC. A case-control study from Iran Genet Mol Res. 2010, 9 (1): 239-249.
CAS
PubMed
Google Scholar
Sarbia M, Bitzer M, Siegel D, Ross D, Schulz WA, Zotz RB, Kiel S, Geddert H, Kandemir Y, Walter A: Association between NAD(P)H: quinone oxidoreductase 1 (NQ01) inactivating C609T polymorphism and adenocarcinoma of the upper gastrointestinal tract. Int J Cancer. 2003, 107 (3): 381-386. 10.1002/ijc.11430.
Article
CAS
PubMed
Google Scholar
von Rahden BH, Stein HJ, Langer R, von Weyhern CW, Schenk E, Doring C, Siewert JR, Hofler H, Sarbia M: C609T polymorphism of the NAD(P)H:quinone oxidoreductase I gene does not significantly affect susceptibility for esophageal adenocarcinoma. Int J Cancer. 2005, 113 (3): 506-508. 10.1002/ijc.20576.
Article
CAS
PubMed
Google Scholar
Zhang J, Schulz WA, Li Y, Wang R, Zotz R, Wen D, Siegel D, Ross D, Gabbert HE, Sarbia M: Association of NAD(P)H: quinone oxidoreductase 1 (NQO1) C609T polymorphism with esophageal squamous cell carcinoma in a German Caucasian and a northern Chinese population. Carcinogenesis. 2003, 24 (5): 905-909. 10.1093/carcin/bgg019.
Article
PubMed
Google Scholar
Zhang JH, Li Y, Wang R, Geddert H, Guo W, Wen DG, Chen ZF, Wei LZ, Kuang G, He M: NQO1 C609T polymorphism associated with esophageal cancer and gastric cardiac carcinoma in North China. World J Gastroenterol. 2003, 9 (7): 1390-1393.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhang WC, Yin LH, Pu YP, Liang GY, Hu X, Liu YZ, Cui YS: Relationship between quinone oxidoreductase1 gene ns-cSNP and genetic susceptibility of esophageal cancer. Zhonghua Yu Fang Yi Xue Za Zhi. 2006, 40 (5): 324-327.
CAS
PubMed
Google Scholar
Traver RD, Horikoshi T, Danenberg KD, Stadlbauer TH, Danenberg PV, Ross D, Gibson NW: NAD(P)H:quinone oxidoreductase gene expression in human colon carcinoma cells: characterization of a mutation which modulates DT-diaphorase activity and mitomycin sensitivity. Cancer Res. 1992, 52 (4): 797-802.
CAS
PubMed
Google Scholar
Rauth AM, Goldberg Z, Misra V: DT-diaphorase: possible roles in cancer chemotherapy and carcinogenesis. Oncol Res. 1997, 9 (6–7): 339-349.
CAS
PubMed
Google Scholar
Wang Z, Hu J, Zhong J: Meta-analysis of the NAD(P)H: quinine oxidoreductase 1 gene 609 C > T polymorphism with esophageal cancer risk. DNA Cell Biol. 2012, 31 (4): 560-567. 10.1089/dna.2011.1332.
Article
PubMed
Google Scholar